首页> 美国卫生研究院文献>Endocrinology >Substitution of Serine for Proline in the Active Center of Type 2 Iodothyronine Deiodinase Substantially Alters Its in Vitro Biochemical Properties with Dithiothreitol But Not Its Function in Intact Cells
【2h】

Substitution of Serine for Proline in the Active Center of Type 2 Iodothyronine Deiodinase Substantially Alters Its in Vitro Biochemical Properties with Dithiothreitol But Not Its Function in Intact Cells

机译:丝氨酸取代脯氨酸在2型碘甲状腺素脱碘酶的活性中心可实质性地改变其与二硫苏糖醇的体外生化特性但在完整细胞中则无作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

T4 must be activated by its monodeiodination to T3 by type 1 or 2 iodothyronine deiodinase (D1 and D2). Recent studies show that despite an approximately 2000-fold higher Michaelis constant (Km; T4) for D1 than for D2 using dithiothreitol (DTT) as cofactor, D1 expressed in intact cells produces T3 at free T4 concentrations many orders of magnitude below its Km. To understand the factors regulating D1 and D2 catalysis in vivo, we studied a mutant D2 with a proline at position 135 of the active center of D2 replaced with a serine, as found in D1. The P135S D2 enzyme has many D1-like properties, a Km (T4) in the micromolar range, ping-pong kinetics with DTT, and sensitivity to 6n-propylthiouracil (PTU) in vitro. Unexpectedly, when the P135S D2 was expressed in HEK-293 cells and exposed to 2–200 pm free T4, the rate of T4 to T3 conversion was identical with D2 and conversion was insensitive to PTU. Using glutathione as a cofactor in vitro resulted in a marked decrease in the Km (T4) (as also occurs for D1), it showed sequential kinetics with T4 and it was sensitive to PTU but was resistant when HEK-293 cytosol was used as a cofactor. Thus, the in vivo catalytic properties of the P135S D2 mutant are more accurately predicted from in vitro studies with weak reducing agents, such as glutathione or endogenous cofactors, than by those with DTT.
机译:必须通过1型或2型碘甲状腺素脱碘酶(D1和D2)将T4单碘化为T3来激活T4。最近的研究表明,尽管使用二硫苏糖醇(DTT)作为辅因子,D1的米氏常数(Km; T4)大约比D2高2000倍,但完整细胞中表达的D1在游离T4浓度下会比其Km低许多个数量级。为了了解在体内调节D1和D2催化的因素,我们研究了突变D2,在D2活性中心135位上的脯氨酸被丝氨酸取代,如D1所示。 P135S D2酶具有许多类似D1的特性,微摩尔范围内的Km(T4),具有DTT的乒乓动力学以及在体外对6n-丙基硫氧嘧啶(PTU)的敏感性。出乎意料的是,当P135S D2在HEK-293细胞中表达并暴露于2–200 pm的游离T4中时,T4到T3的转化率与D2相同,并且转化对PTU不敏感。在体外使用谷胱甘肽作为辅因子会导致Km(T4)显着下降(D1也是如此),它与T4表现出连续的动力学,并且对PTU敏感,但是当使用HEK-293胞浆作为抗癌药物时具有耐药性。辅助因子。因此,与带有DTT的还原剂相比,使用弱还原剂(如谷胱甘肽或内源性辅因子)的体外研究更准确地预测了P135S D2突变体的体内催化特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号